Namibia recorded its first COVID-19 case on 14 March 2020, with cumulative cases reaching 15,773 and 118 deaths by 10 December 2020. Namibia has done relatively well to contain the outbreak.
However, positivity rates have shown a consistent increase above 5 percent in quarter 4 of 2020, necessitati...ng renewed attention to surveillance and outbreak control in 2021.
more
MENSAJES A INSTITUCIONES RESPONSABLES DEL AGUA
Y SANEAMIENTO
Los responsables de agua y saneamiento tienen un rol relevante en la prevención
y control de COVID-19, por lo que es importante que los servicios de agua,
saneamiento e higiene sean gestionados de forma segura, garantizando el
cumpli...miento de las normativas nacionales.
more
Este cuestionario tiene como objetivo mejorar los criterios de inclusión al momento de entregar o indicar el Test de Sangre Oculta en Materia Fecal (TSOMF) a personas entre 50 y 75 años.
This unit discusses the factors and determinants associated with the spread of Coronavirus
Jesuit Worldwide Learning invites you to learn facts and test your knowledge on the ongoing pandemic caused by Coronavirus (COVID 19) through a fun-interactive crash course! Access is free! You have only to s...ign up
more
Listening. Learning. Reading
A Comprehensive Review of Published GRE - Validity Data
A Summary from ETS
Accessed January 2019, publication date unknown.
DHS Working Papers No. 86
Guide to enrolment for antimicrobial resistance national focal points
The pharmacological treatment of heart failure has evolved over the last three decades since the demonstration of the effect of angiotensinconverting enzyme inhibitors on major cardiovascular events in patients with heart failure with reduced ejection fraction. Composite analysis of heart failure wi...th reduced ejection fraction trials and the recent identification of newer drug treatments show early benefits on the major cardiovascular outcomes, ushering in a change of the treatment strategy; from a ‘sequential’ initiation of the treatments to a ‘simultaneous’ initiation to harness the early benefits. The adoption and implementation of these changes at the bedside have been dismal in many healthcare settings. Papua New Guinea, like many other lower-to-middle-income countries, is facing many barriers that impact on the care of heart failure patients. It needs to adopt and implement these changes to provide evidence-based treatment for its people with heart failure with reduced ejection fraction.
more